News
ZOM
0.1760
-0.62%
-0.0011
Weekly Report: what happened at ZOM last week (0513-0517)?
Weekly Report · 6d ago
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. The Dow Jones index closed higher by around 350 points on Wednesday. Insider transactions for penny stocks are a good sign for investors and traders interested in penny stocks. Sabre Corporation and Zomedica Corp. Have had recent notable insider transactions.
Benzinga · 05/16 11:55
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
Dow Jones index closed lower by over 80 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Recent notable insider transactions for penny stocks include Earth Science Tech, Inc. And Zomedica Corp.
Benzinga · 05/14 13:01
Weekly Report: what happened at ZOM last week (0506-0510)?
Weekly Report · 05/13 09:48
Zomedica Corp. Form 10-Q for the Quarterly Period Ended March 31, 2024
Press release · 05/10 17:57
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Novavax stock is rocketing more than 112% alongside its Q1 earnings report and a deal with Sanofi. Earnings reports continue to be a major mover of shares this morning as companies report their Q1 2024 results. The biggest pre-market stock movers include Novavax and AEye.
Investorplace · 05/10 11:30
ZOM Stock Earnings: Zomedica Misses Revenue for Q1 2024
Zomedica just reported results for the first quarter of 2024. The company reported earnings per share of -1 cent and revenue of $6.26 million. This was 23.45% worse than the analyst estimate of $8.18 million for the same period.
Investorplace · 05/10 01:56
Zomedica Continues To Expect FY24 Revenue Of $31M-$35M, Est $34.1M
Benzinga · 05/09 21:42
Zomedica Q1 2024 GAAP EPS $(0.01) Down From $(0.01) YoY, Sales $6.262M Miss $8.184M Estimate
Zomedica reports quarterly losses of $0.01 per share. Sales of $6.262 million missed the analyst consensus estimate of $8.184 million by 23.48%. Company reported quarterly sales of $5.482 million the same period last year..
Benzinga · 05/09 21:25
Zomedica Reports Record Q1 Growth and Optimism
TipRanks · 05/09 21:07
Zomedica Secures CE Certification for VetGuardian, Expanding Access to Contactless Monitoring for Vets in the EU
Zomedica Corp. Has received CE certification for its VetGuardian remote contactless monitoring system. The system meets all EU health, safety, and environmental protection standards. The company says the milestone expands the market size for the system. Zomedica is a veterinary health company offering products for equine and companion animals.
Benzinga · 05/06 10:35
Weekly Report: what happened at ZOM last week (0429-0503)?
Weekly Report · 05/06 09:50
Weekly Report: what happened at ZOM last week (0422-0426)?
Weekly Report · 04/29 09:52
Weekly Report: what happened at ZOM last week (0415-0419)?
Weekly Report · 04/22 09:49
Weekly Report: what happened at ZOM last week (0408-0412)?
Weekly Report · 04/15 09:46
Weekly Report: what happened at ZOM last week (0401-0405)?
Weekly Report · 04/08 09:47
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
Zomedica just reported results for the fourth quarter of 2023. The company reported revenue of $7.34 million. Zomedica reported earnings per share of -2.3 cents. This was 4.81% better than the analyst estimate for the quarter.
Investorplace · 04/02 00:53
Zomedica Achieves Record Revenue and Strong Growth
TipRanks · 04/01 21:37
Zomedica Q4 2023 GAAP EPS $(0.02), Sales $7.337M Beat $7.000M Estimate
Benzinga · 04/01 20:28
Zomedica reports Q4 results
Seeking Alpha · 04/01 20:15
More
Webull provides a variety of real-time ZOM stock news. You can receive the latest news about Zomedica Corp through multiple platforms. This information may help you make smarter investment decisions.
About ZOM
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.